Comparative effect of l-CCG-I, DCG-IV and γ-carboxy-l-glutamate on all cloned metabotropic glutamate receptor subtypes

Neuropharmacology

Volumn 37, Issue 8, 1998, Pages 1043-1051

  Brabet, Isabelle ^a   Parmentier, Marie Laure ^a,c   De Colle, Cyril ^a   Bockaert, Joël ^a   Acher, Francine ^b   Pin, Jean Philippe ^a  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Antagonists; DCG IV; Gla; mGlu receptor pharmacology

Indexed keywords

2 (2,3 DICARBOXYCYCLOPROPYL)GLYCINE; 4 CARBOXYGLUTAMIC ACID; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; METABOTROPIC RECEPTOR; RECEPTOR SUBTYPE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

1-CARBOXYGLUTAMIC ACID; AMINO ACIDS, DICARBOXYLIC; CELL LINE; CLONING, MOLECULAR; CYCLOPROPANES; EXCITATORY AMINO ACID AGONISTS; GLYCINE; HUMANS; RECEPTORS, METABOTROPIC GLUTAMATE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031713304     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00091-4     Document Type: Article

References (41)

1. Acher, F., Tellier, F., Azerad, R., Brabet, I., Fagni, L., Pin, J.-P., 1997. Synthesis and pharmacological characterization of aminocyclopentane tricarboxylic acids (ACPT): new tools to discriminate between metabotropic glutamate receptor subtypes. J. Med. Chem. 40, 3119-3129.
2. Ahmadian, H., Nielsen, B., Bräuner-Osborne, H., Johansen, T.N., Stensbøl, T.B., Sløk, F.A., Sekiyama, N., Nakanishi, S., Krogsgaard-Larsen, P., Madsen, U., 1997. (S)-Homo-AMPA, a specific agonist at the mGlu6 subtype of metabotropic glutamic acid receptors. J. Med. Chem. 40, 3700-3705.
3. Annoura, H., Fukunaga, A., Uesugi, M., Tatsuoka, T., Horikawa, Y., 1996. A novel class of antagonists for metabotropic glutamate receptors, 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylates. Bioorg. Med. Chem. Lett. 6, 763-766.
4. Baker, S.R., Goldsworthy, J., Harden, R.C., Salhoff, C.R., Schoepp, D.D., 1995. Enzymatic resolution and pharmacological activity of the enantiomers of 3,5-dihydroxyphenylglycine, a metabotropic glutamate receptor agonist. Bioorg. Med. Chem. Lett. 5, 223-228.
5. Brabet, I., Mary, S., Bockaert, J., Pin, J.-P., 1995. Phenylglycine derivatives discriminate between mGluRl and mGluR5 mediated responses. Neuropharmacology 34, 895-903.
6. Bräuner-Osborne, H., Nielsen, B., Stensbol, T.B., Johansen, T.N., Skjæbæk, N., Krogsgaard-Larsen, P., 1997. Molecular pharmacology of 4-substituted glutamic acid analogues at ionotropic and metabotropic excitatory amino acid receptors. Eur. J. Pharmacol. 335, R1-R3.
7. Clark, B.P., Baker, S.R., Goldsworthy, J., Harris, J.R., Kingston, A.E., 1997. (+)-2-Methyl-4-carboxyphenylglycine (LY367385) selectively antagonises metabotropic glutamate mGluR1 receptors. Bioorg. Med. Chem. Lett. 7, 2777-2780.
8. Conklin, B.R., Farfel, Z., Lustig, K.D., Julius, D., Bourne, H.R., 1993. Substitution of three amino acids switches receptor specificity of Gqα to that of Giα. Nature 363, 274-276.
9. Conn, P., Pin, J.-P., 1997. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37, 205-237.
10. Doherty, A.J., Palmer, M.J., Henley, J.M., Collingridge, G.L., Jane, D.E., 1997. (RS)-2-Chloro-5-hydroxyphenylglycine (CHPG) activates mGlu(5), but not mGlu(1), receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology 36, 265-267.
11. Escribano, A., Ezquerra, J., Pedregal, C., Rubio, A., Yrurelagoyena, B., Baker, S.R., Wright, R., Johnson, B.G., Schoepp, D.D., 1998. (2S,4S)-2-Amino-4-(2,2-diphenylethyl)pentanedioic acid selective group 2 metabotropic glutamate receptor antagonist. Bioorg. Med. Chem. Lett. 8, 765-770.
12. Flor, P.J., Lindauer, K., Püttner, I., Rüegg, D., Lukic, S., Knöpfel, T., Kuhn, R., 1995. Molecular cloning, functional expression and pharmacological characterization of the human metabotropic glutamate receptor type 2. Eur. J. Neurosci. 7, 622-629.
13. Flor, P.J., Gomeza, J., Tones, M.A., Kuhn, R., Pin, J.P., Knöpfel, T., 1996. The C-terminal domain of the mGluR1 metabotropic glutamate receptor affects sensitivity to agonists. J. Neurochem. 67, 58-63.
14. Gomeza, J., Mary, S., Brabet, I., Parmentier, M.-L., Restituito, S., Bockaert, J., Pin, J.-P., 1996. Coupling of mGluR2 and mGluR4 to Gα15, Gα16 and chimeric Gαq/i proteins: characterization of new antagonists. Mol. Pharmacol. 50, 923-930.
15. Hayashi, Y., Tanabe, Y., Aramori, I., Masu, M., Shimamoto, K., Ohfune, Y., Nakanishi, S., 1992. Agonist analysis of 2-(carboxycyclopropyl)glycine isomers for cloned metabotropic glutamate receptor subtypes expressed in Chinese hamster ovary cells. Br. J. Pharmacol. 107, 539-543.
16. Hayashi, Y., Momiyama, A., Takahashi, T., Ohishi, H., Ogawa-Meguro, R., Shigemoto, R., Mizuno, N., Nakanishi, S., 1993. Role of a metabotropic glutamate receptor in synaptic modulation in the accessory olfactory bulb. Nature 366, 687-690.
17. Ito, I., Kohda, A., Tanabe, S., Hirose, E., Hayashi, M., Mitsunaga, S., Sugiyama, H., 1992. 3,5-Dihydroxyphenylglycine: a potent agonist of metabotropic glutamate receptors. Neuroreport 3, 1013-1016.
18. Jane, D.E., Jones, P.L.S.J., Pook, P.C.-K., Tse, H.-W., Watkins, J.C., 1994. Actions of two new antagonists showing selectivity for different sub-types of metabotropic glutamate receptor in the neonatal rat spinal cord. Br. J. Pharmacol. 112, 809-816.
19. Joly, C., Gomeza, J., Brabet, I., Curry, K., Bockaert, J., Pin, J.-P., 1995. Molecular, functional and pharmacological characterization of the metabotropic glutamate receptor type 5 splice variants: comparison with mGluR1. J. Neurosci. 15, 3970-3981.
20. Kanai, Y., Hediger, M.A., 1992. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360, 467-471.
21. Knöpfel, T., Lukic, S., Leonardt, T., Flor, P.J., Kuhn, R., Gasparini, F., 1995. Pharmacological characterization of MCCG and MAP4 at the mGluR1b, mGluR2 and mGluR4a human metabotropic glutamate receptor subtypes. Neuropharmacology 34, 1099-1102.
22. Nakanishi, S., 1992. Molecular diversity of glutamate receptors and implications for brain function. Science 258, 597-603.
23. Nakanishi, S., 1995. Second-order neurones and receptor mechanisms in visual- and olfactory-information processing. Trends Neurosci. 18, 359-364.
24. Offermanns, S., Simon, M.I., 1995. Gα15 and Gα16 couple a wide variety of receptors to phospholipase C. J. Biol. Chem. 270, 15175-15180.
25. Ornstein, P.L., Bleisch, T.J., Arnold, M.B., Kennedy, J.H., Wright, R.A., Johnson, B.G., Tizzano, J.P., Helton, D.R., Kallman, M.J., Schoepp, D.D., Herin, M., 1998a. 2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability. J. Med. Chem. 41, 358-378.
26. Ornstein, P.L., Bleisch, T.J., Arnold, M.B., Wright, R.A., Johnson, B.G., Schoepp, D.D., 1998b. 2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitution. J. Med. Chem. 41, 346-357.
27. Parmentier, M.L., Joly, C., Restituito, S., Bockaert, J., Grau, Y., Pin J.-P., 1998. The G-protein coupling profile of metabotropic glutamate receptors, as determined with exogenous G-proteins, is independent of their ligand recognition domain. Mol. Pharmacol. 53, 778-786.
28. Pellicciari, R., Marinozzi, M., Natalini, B., Costantino, G., Luneia, R., Giorgi, G., Moroni, F., Thomsen, C., 1996. Synthesis and Pharmacological characterization of all sixteen stereoisomers of 2-(2′-Carboxy-3′-phenylcyclopropyl)glycine. Focus on (2S,1′S, 2′S,3′R)-2-(2′-carboxy-3′-phenylcyclopropyl)glycine, a novel and selective group-II metabotropic glutamate receptor antagonist. J. Med. Chem. 39, 2259-2269.
29. Pin, J.-P., Joly, C., Heinemann, S.F., Bockaert, J., 1994. Domains involved in the specificity of G protein activation in phospholipase C coupled metabotropic glutamate receptor. EMBO J. 13, 342-348.
30. Roberts, P.J., 1995. Pharmacological tools for the investigation of metabotropic glutamate receptors (mGluRs): phenylglycine derivatives and other selective antagonists - an update. Neuropharmacology 34, 813-819.
31. Saugstad, J.A., Kinzie, J.M., Shinohara, M.M., Segerson, T.P., Westbrook, G.L., 1997. Cloning and expression of rat metabotropic glutamate receptor 8 reveals a distinct pharmacological profile. Mol. Pharmacol. 51, 119-125.
32. Schoepp, D.D., Goldsworthy, J., Johnson, B.G., Salhoff, C.R., Baker, S.R., 1994. 3,5-Dihydroxyphenylglycine is a highly selective agonist for phosphoinositide-linked metabotropic glutamate receptors in the rat hippocampus. J. Neurochem. 63, 769-772.
33. Schoepp, D.D., Salhoff, C.R., Wright, R.A., Johnson, B.G., Burnett, J.P., Mayne, N.G., Belagaje, R., Wu, S., Monn, J.A., 1996. The novel metabotropic glutamate agonist 2R.4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptors. Neuropharmacology 35, 1661-1672.
34. Schoepp, D.D., Johnson, B.G., Wright, R.A., Salhoff, C.R., Mayne, N.G., Wu, S., Cockerham, S.L., Burnett, J.P., Belegaje, R., Bleakman, D., Monn, J.A., 1997. LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors. Neuropharmacology 36, 1-11.
35. Tellier, F., Acher, F., Brabet, I., Pin, J.-P., Bockaert, J., Azerad, R., 1995. Synthesis of conformationally-constrained stereospecific analogs of glutamic acid as antagonists of metabotropic receptors. Bioorg. Med. Chem. Lett. 5, 2627-2632.
36. Tellier, F., Acher, F., Brabet, I., Pin, J.-P., Azerad, R., 1998. Aminobicyclo[2.2.1.]heptane dicarboxylic acids (ABHD), analogs of ACPD and glutamic acid: synthesis and pharmacological activity on metabotropic receptors mGluRla and mGluR2. Bioorg. Med. Chem. 6, 195-208.
37. Thomsen, C., Bruno, V., Nicoletti, F., Marinozzi, M., Pellicciari, R., 1996. (2S,1′S,2′S,3′R)-2-(2′-Carboxy-3′- phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors. Mol. Pharmacol. 50, 6-9.
38. Todeschi, N., Gharbi-Benarous, J., Acher, F., Larue, V., Pin, J.-P., Bockaert, J., Azerad, R., Girault, J.-P., 1997. Conformational analysis of glutamic acid analogues as probes of glutamate receptors using molecular modelling and NMR methods. Comparison with specific agonists. Bioorg. Med. Chem. 5, 335-352.
39. Tückmantel, W., Kozikowski, A.P., Wang, S., Pshenichkin, S., Wroblewski, J.T., 1997. Synthesis, molecular modeling, and biology of the 1-benzyl derivative of APDC - an apparent niGluR6 selective ligand. Bioorg. Med. Chem. Lett. 7, 601-606.
40. Wermuth, C.G., Mann, A., Schoenfelder, A., Wright, R.A., Johnson, B.G., Burnett, J.P., Mayne, N.G., Schoepp, D.D., 1996. (2S,4S)-2-Amino-4-(4,4-diphenylbut-1-yl)-pentane-1.5-dioic acid: a potent and selective antagonist for metabotropic glutamate receptors negatively linked to adenylate cyclase. J. Med. Chem. 39, 814-816.
41. Wroblewska, B., Wroblewski, J.T., Pshenichkin, S., Surin, A., Sullivan, S.E., Neale, J.H., 1997. N-Acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells. J. Neurochem. 69, 174-181.